The Pfizer Documents - July 2022 Update - 磁力管家 - 男人都爱上的磁力连接搜索引擎

BT种子名称

分享给好友

BT种子基本信息

种子哈希：098bdf41ddb0e77fc3e6a05dae59dc709f272abe
文档大小：12.6 GB
文档个数：725个文档
下载次数：1769次
下载速度：极快
收录时间：2024-05-30
最近下载：2025-05-10
DMCA/屏蔽：DMCA/屏蔽

下载磁力链接

magnet:?xt=urn:btih:098BDF41DDB0E77FC3E6A05DAE59DC709F272ABE
复制磁力链接到utorrent、Bitcomet、迅雷、115、百度网盘等下载工具进行下载。

下载BT种子

磁力链接种子下载迅雷下载二维码迅雷看看
磁力链接在线播放？试试百度云网盘离线下载播放！

The Pfizer Documents - July 2022 Update的二维码

文档列表

pd-production-070122/FDA-CBER-2021-5683-0225598 to -0282129_125742_S1_M5_c4591001-A-Supp-D-adfacevd.xpt 4.2 GB
pd-production-050222/FDA-CBER-2021-5683-0066701 to -0123167_125742_S1_M5_c4591001-A-D-adfacevd.xpt 4.1 GB
pd-production-060122/FDA-CBER-2021-5683-0142307 to -0149081_125742_S1_M5_c4591001-A-Supp-D-adcevd.xpt 446.7 MB
pd-production-050222/FDA-CBER-2021-5683-0059000 to -0065773_125742_S1_M5_c4591001-A-D-adcevd.xpt 413.5 MB
pd-production-060122/FDA-CBER-2021-5683-0149082 to -0158559_125742_S1_M5_c4591001-S-D-ce.xpt 386.0 MB
pd-production-060122/FDA-CBER-2021-5683-0196049 to -0205317_125742_S1_M5_c4591001-S-Supp-D-ce.xpt 378.9 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-adverse-events.pdf 192.3 MB
pd-production-050222/FDA-CBER-2021-5683-0123168 to -0126026_125742_S1_M5_c4591001-A-D-adva.xpt 170.8 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-lab-measurements.pdf 95.5 MB
pd-production-070122/FDA-CBER-2021-5683-0286267 to -0296903_125742_S1_M5_c4591001-S-Supp-D-suppce.xpt 87.2 MB
pd-production-050222/125742_S1_M5_5351_c4591001-interim-mth6-randomization-sensitive.pdf 68.1 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-randomization-sensitive.pdf 62.3 MB
pd-production-070122/FDA-CBER-2021-5683-0296904 to -0307543_125742_S1_M5_c4591001-S-D-suppce.xpt 56.2 MB
pd-production-070122/FDA-CBER-2021-5683-0282366 to -0285643_125742_S1_M5_c4591001-S-D-mb.xpt 50.5 MB
pd-production-060122/FDA-CBER-2021-5683-0159487 to -0162689_125742_S1_M5_c4591001-S-D-ec.xpt 48.8 MB
pd-production-070122/FDA-CBER-2021-5683-0225100 to -0225597_125742_S1_M5_c4591001-A-D-adcm.xpt 48.7 MB
pd-production-060122/FDA-CBER-2021-5683-0162690 to -0165892_125742_S1_M5_c4591001-S-D-ex.xpt 46.9 MB
pd-production-060122/FDA-CBER-2021-5683-0205318 to -0208520_125742_S1_M5_c4591001-S-Supp-D-ex.xpt 46.9 MB
pd-production-050222/FDA-CBER-2021-5683-0065774 to -0066700_125742_S1_M5_c4591001-A-D-addv.xpt 45.7 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-report-body.pdf 43.7 MB
pd-production-060122/FDA-CBER-2021-5683-0208521 to -0216666_125742_S1_M5_c4591001-S-Supp-D-suppvs.xpt 41.1 MB
pd-production-060122/FDA-CBER-2021-5683-0187906 to -0196048_125742_S1_M5_c4591001-S-D-suppvs.xpt 41.0 MB
pd-production-030122/125742_S1_M5_5351_c4591001-interim-mth6-protocol.pdf 38.7 MB
pd-production-060122/125742_S1_M5_5351_c4591001-fa-interim-adverse-events.pdf 33.3 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-protocol.pdf 32.8 MB
pd-production-060122/FDA-CBER-2021-5683-0165893 to -0168682_125742_S1_M5_c4591001-S-D-is.xpt 30.8 MB
pd-production-040122/125742_S1_M5_5351_c4591001-interim-mth6-demographics.pdf 29.1 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-demographics.pdf 29.1 MB
pd-production-060122/FDA-CBER-2021-5683-0174607 to -0178318_125742_S1_M5_c4591001-S-D-suppdv.xpt 24.5 MB
pd-production-060122/FDA-CBER-2021-5683-0182981 to -0187905_125742_S1_M5_c4591001-S-D-suppmh.xpt 22.7 MB
pd-production-070122/125742_S1_M5_5351_c4591001-fa-interim-narrative-sensitive.pdf 19.8 MB
pd-production-030122/125742_S1_M5_c4591001-T-S-updated-reacto-tlf.pdf 18.3 MB
pd-production-060122/FDA-CBER-2021-5683-0171524 to -0174606_125742_S1_M5_c4591001-S-D-suppds.xpt 17.8 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-excluded-patients-sensitive.pdf 16.5 MB
pd-production-070122/125742_S2_M5_5354_wi235284-protocol.pdf 16.3 MB
pd-production-120121/Pages-42-289-Section-5.2-listing-clinical-sites-cvs_Part-B.pdf 14.4 MB
pd-production-060122/FDA-CBER-2021-5683-0169082 to -0171523_125742_S1_M5_c4591001-S-D-suppdm.xpt 14.4 MB
pd-production-013122/CRFs-for-site-1128.pdf 14.2 MB
pd-production-123021/CRFs-for-site-1081.pdf 13.8 MB
pd-production-030122/125742_S1_M5_5351_c4591001-interim-mth6-oversight-committees.pdf 13.6 MB
pd-production-120121/Pages-42-289-Section-5.2-listing-clinical-sites-cvs_Part-A.pdf 12.9 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements.pdf 12.6 MB
pd-production-050222/125742_S1_M5_5351_c4591001-interim-mth6-sponsor-signature.pdf 12.5 MB
pd-production-060122/FDA-CBER-2021-5683-0158560 to -0159486_125742_S1_M5_c4591001-S-D-dv.xpt 12.0 MB
pd-production-011822/CRFs-for-site-1096.pdf 11.8 MB
pd-production-060122/125742_S1_M5_5351_c4591001-interim-mth6-publications.pdf 11.7 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-interlab-standard.pdf 11.4 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-protocol.pdf 11.0 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-publications.pdf 10.2 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-sample-crf.pdf 9.5 MB
pd-production-070122/FDA-CBER-2021-5683-0285652 to -0286071_125742_S1_M5_c4591001-S-D-pe.xpt 9.3 MB
pd-production-060122/FDA-CBER-2021-5683-0178319 to -0180190_125742_S1_M5_c4591001-S-D-suppho.xpt 8.6 MB
pd-production-111721/5.2-listing-of-clinical-sites-and-cvs-pages-1-41.pdf 8.4 MB
pd-production-060122/FDA-CBER-2021-5683-0180191 to -0182980_125742_S1_M5_c4591001-S-D-suppis.xpt 8.4 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-iec-irb-consent-form.pdf 7.9 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-compliance.pdf 7.8 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-adverse-events.pdf 7.4 MB
pd-production-121321/STN-125742_0_0-Section-2.7.4-summary-clin-safety.pdf 6.8 MB
pd-production-121321/CRFs-for-site-1055.pdf 6.7 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-investigators.pdf 6.6 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-lab-measurements-sensitive.pdf 5.7 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-sample-crf.pdf 5.7 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-sap.pdf 5.7 MB
pd-production-050222/125742_S1_M5_5351_c4591001-interim-mth6-sample-crf.pdf 5.6 MB
pd-production-030122/125742_S1_M4_4223_R-20-0072.pdf 5.5 MB
pd-production-030122/125742_S1_M1_3674.pdf 5.4 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements-sensitive.pdf 5.0 MB
pd-production-060122/STN 125742-0-0 Section 2.5 Clinical Overview reissue.pdf 4.9 MB
pd-production-121321/STN-125742_0_0-Section-2.5-Clinical-Overview.pdf 4.4 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-discontinued-patients.pdf 4.4 MB
pd-production-070122/FDA-CBER-2021-5683-0282130 to -0282328_125742_S1_M5_c4591001-S-D-cm.xpt 4.2 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061040.pdf 4.0 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-synopsis.pdf 3.9 MB
pd-production-030122/125742_S1_M1_financial-cert-3454.pdf 3.6 MB
pd-production-070122/125742_S1_M5_5351_c4591001-fa-interim-sap.pdf 3.4 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031113.pdf 3.4 MB
pd-production-121321/STN-125742_0_0-Section-2.7.3-Summary-of-Clinical-Efficacy.pdf 3.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131786.pdf 3.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071050.pdf 3.1 MB
pd-production-060122/125742_S1_M5_5351_c4591001-fa-interim-discontinued-patients.pdf 3.1 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-sap.pdf 3.0 MB
pd-production-050222/125742_S1_M5_c4591001-S-acrf.pdf 3.0 MB
pd-production-050222/125742_S1_M5_c4591001-S-Supp-acrf.pdf 3.0 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-excluded-patients-sensitive.pdf 2.9 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131176.pdf 2.9 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071306.pdf 2.9 MB
pd-production-060122/FDA-CBER-2021-5683-0168683 to -0169081_125742_S1_M5_c4591001-S-D-suppcm.xpt 2.9 MB
pd-production-030122/125742_S1_M1_waiver-req-designated-suffix.pdf 2.9 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031038.pdf 2.8 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031065.pdf 2.8 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061176.pdf 2.8 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1001-10011093.pdf 2.8 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-patient-batches.pdf 2.7 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151238.pdf 2.6 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031186.pdf 2.5 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051293.pdf 2.5 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-efficacy-response.pdf 2.5 MB
pd-production-032422/125742_S1_M1_priority-review-request.pdf 2.5 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131699.pdf 2.5 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-demographics.pdf 2.4 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131554.pdf 2.4 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-sponsor-signature.pdf 2.4 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131190.pdf 2.4 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-oversight-committees.pdf 2.4 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-errata.pdf 2.4 MB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851018.pdf 2.4 MB
pd-production-030122/125742_S1_M5_c4591001-T-S-final-reacto-tables-track.pdf 2.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131718.pdf 2.3 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1001-10011100.pdf 2.2 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061052.pdf 2.2 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061094.pdf 2.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071097.pdf 2.2 MB
pd-production-060122/125742_S1_M5_5314_shi-sop-10011.pdf 2.2 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-compliance.pdf 2.1 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-excluded-patients.pdf 2.1 MB
.pad/2093792 2.1 MB
.pad/2092509 2.1 MB
.pad/2088512 2.1 MB
.pad/2088447 2.1 MB
.pad/2088427 2.1 MB
.pad/2088038 2.1 MB
.pad/2087828 2.1 MB
.pad/2087828 2.1 MB
.pad/2087781 2.1 MB
.pad/2087731 2.1 MB
.pad/2087729 2.1 MB
.pad/2087487 2.1 MB
.pad/2087339 2.1 MB
.pad/2087144 2.1 MB
.pad/2087023 2.1 MB
.pad/2086653 2.1 MB
.pad/2086558 2.1 MB
.pad/2085842 2.1 MB
.pad/2085796 2.1 MB
.pad/2085790 2.1 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-discontinued-patients.pdf 2.1 MB
.pad/2085324 2.1 MB
.pad/2085199 2.1 MB
.pad/2085163 2.1 MB
.pad/2084592 2.1 MB
.pad/2084417 2.1 MB
.pad/2083861 2.1 MB
.pad/2082947 2.1 MB
.pad/2082484 2.1 MB
.pad/2082135 2.1 MB
.pad/2082049 2.1 MB
.pad/2081683 2.1 MB
.pad/2081232 2.1 MB
.pad/2079719 2.1 MB
.pad/2078783 2.1 MB
.pad/2078228 2.1 MB
.pad/2077840 2.1 MB
.pad/2077226 2.1 MB
.pad/2077131 2.1 MB
.pad/2075303 2.1 MB
.pad/2075106 2.1 MB
.pad/2074342 2.1 MB
.pad/2073880 2.1 MB
.pad/2072639 2.1 MB
.pad/2072549 2.1 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-sponsor-personnel-list.pdf 2.1 MB
.pad/2069393 2.1 MB
.pad/2067726 2.1 MB
.pad/2067255 2.1 MB
.pad/2064193 2.1 MB
.pad/2061533 2.1 MB
.pad/2060836 2.1 MB
.pad/2059312 2.1 MB
.pad/2055035 2.1 MB
.pad/2052874 2.1 MB
.pad/2051278 2.1 MB
pd-production-070122/125742_S2_M1_loa-dmf-031786-vials.pdf 2.0 MB
.pad/2047036 2.0 MB
pd-production-122221/Supplemental-Index-12-22-21.pdf 2.0 MB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851129.pdf 2.0 MB
.pad/2023871 2.0 MB
.pad/2023632 2.0 MB
.pad/2020724 2.0 MB
.pad/2020648 2.0 MB
.pad/2019948 2.0 MB
.pad/2019552 2.0 MB
.pad/2018038 2.0 MB
.pad/2015600 2.0 MB
.pad/2014149 2.0 MB
.pad/2011782 2.0 MB
.pad/2011000 2.0 MB
.pad/2008239 2.0 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071280.pdf 2.0 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071117.pdf 2.0 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051054.pdf 2.0 MB
.pad/1969297 2.0 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1128-11281009 reissue.pdf 2.0 MB
.pad/1958734 2.0 MB
.pad/1937657 1.9 MB
.pad/1935680 1.9 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071192.pdf 1.9 MB
.pad/1909495 1.9 MB
.pad/1909495 1.9 MB
.pad/1909495 1.9 MB
.pad/1909495 1.9 MB
.pad/1909495 1.9 MB
.pad/1909495 1.9 MB
.pad/1904860 1.9 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-excluded-patients.pdf 1.9 MB
.pad/1899668 1.9 MB
.pad/1897844 1.9 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1012-10121097.pdf 1.9 MB
.pad/1895252 1.9 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-errata.pdf 1.9 MB
.pad/1887761 1.9 MB
.pad/1885619 1.9 MB
.pad/1871120 1.9 MB
.pad/1868899 1.9 MB
.pad/1854768 1.9 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071276.pdf 1.9 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1081-10811194 reissue.pdf 1.8 MB
pd-production-030122/125742_S1_M2_27_synopses-indiv-studies.pdf 1.8 MB
pd-production-030122/125742_S1_M2_27_literature-references.pdf 1.8 MB
.pad/1832352 1.8 MB
pd-production-060122/125742_S1_M2_summary-biopharm.pdf 1.8 MB
.pad/1818848 1.8 MB
pd-production-070122/125742_S2_M1_right-of-reference.pdf 1.8 MB
.pad/1804176 1.8 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1009-10091135.pdf 1.8 MB
pd-production-111721/5.2-tabular-listing.pdf 1.8 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071124.pdf 1.8 MB
.pad/1794426 1.8 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031111.pdf 1.8 MB
.pad/1792114 1.8 MB
.pad/1790159 1.8 MB
.pad/1777447 1.8 MB
.pad/1776506 1.8 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1012-10121112.pdf 1.8 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051387.pdf 1.8 MB
.pad/1757614 1.8 MB
.pad/1746365 1.7 MB
.pad/1740343 1.7 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01_20242.pdf 1.7 MB
.pad/1713856 1.7 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-protocol-deviations.pdf 1.7 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031149.pdf 1.7 MB
.pad/1709969 1.7 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01_20215.pdf 1.7 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1009-10091128.pdf 1.7 MB
.pad/1691225 1.7 MB
pd-production-030122/125742_S1_M2_24_nonclinical-overview.pdf 1.7 MB
.pad/1676688 1.7 MB
.pad/1667904 1.7 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01_10075.pdf 1.7 MB
pd-production-030122/125742_S1_M1_priority-review-request.pdf 1.7 MB
.pad/1660183 1.7 MB
.pad/1659921 1.7 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061098.pdf 1.7 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1012-10121163.pdf 1.6 MB
pd-production-030122/125742_S1_M5_c4591001-A-adrg.pdf 1.6 MB
.pad/1609687 1.6 MB
.pad/1606032 1.6 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1011-10111029.pdf 1.6 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061020.pdf 1.6 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-sponsor-signature.pdf 1.6 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-randomization.pdf 1.6 MB
pd-production-060122/125742_S1_M5_5351_c4591001-fa-interim-protocol-deviations-sensitive.pdf 1.6 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01_20116.pdf 1.6 MB
.pad/1576555 1.6 MB
.pad/1551813 1.6 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031197.pdf 1.5 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071101.pdf 1.5 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1009-10091149.pdf 1.5 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-protocol-deviations.pdf 1.5 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151225.pdf 1.5 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151134.pdf 1.5 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01_10010.pdf 1.5 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051069.pdf 1.5 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071347.pdf 1.5 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051347.pdf 1.5 MB
.pad/1516912 1.5 MB
.pad/1515312 1.5 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031207.pdf 1.5 MB
.pad/1509260 1.5 MB
.pad/1505648 1.5 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131089.pdf 1.5 MB
pd-production-030122/125742_S1_M2_26_pharmkin-written-summary.pdf 1.5 MB
pd-production-050222/125742_S1_M5_c4591001-S-csdrg.pdf 1.5 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1001-10011135.pdf 1.5 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071315.pdf 1.5 MB
.pad/1484552 1.5 MB
.pad/1480471 1.5 MB
.pad/1475698 1.5 MB
.pad/1475451 1.5 MB
pd-production-030122/125742_S1_M4_4223_185350.pdf 1.5 MB
.pad/1466259 1.5 MB
.pad/1466200 1.5 MB
pd-production-050222/125742_S1_M5_bnt162-01-S-acrf.pdf 1.5 MB
.pad/1462066 1.5 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051047.pdf 1.5 MB
.pad/1457924 1.5 MB
.pad/1457347 1.5 MB
.pad/1456559 1.5 MB
.pad/1456467 1.5 MB
.pad/1456458 1.5 MB
.pad/1456310 1.5 MB
.pad/1455323 1.5 MB
.pad/1455055 1.5 MB
.pad/1454285 1.5 MB
.pad/1453899 1.5 MB
.pad/1453711 1.5 MB
.pad/1453115 1.5 MB
.pad/1452969 1.5 MB
.pad/1452648 1.5 MB
.pad/1452410 1.5 MB
.pad/1451109 1.5 MB
.pad/1450554 1.5 MB
.pad/1450394 1.5 MB
.pad/1450371 1.5 MB
.pad/1450049 1.5 MB
.pad/1447677 1.4 MB
.pad/1447505 1.4 MB
.pad/1446252 1.4 MB
.pad/1444971 1.4 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051214.pdf 1.4 MB
.pad/1442879 1.4 MB
.pad/1441672 1.4 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131084.pdf 1.4 MB
pd-production-030122/FDA-CBER-2021-5683-0023150 to -0023454_125742_S1_M5_c4591001-A-define.xml 1.4 MB
.pad/1434362 1.4 MB
.pad/1433248 1.4 MB
.pad/1432149 1.4 MB
.pad/1424982 1.4 MB
.pad/1423524 1.4 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051411.pdf 1.4 MB
.pad/1414356 1.4 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151011.pdf 1.4 MB
.pad/1410900 1.4 MB
.pad/1410832 1.4 MB
.pad/1409120 1.4 MB
pd-production-030122/125742_S1_M2_26_pharmkin-tabulated-summary.pdf 1.4 MB
pd-production-060122/125742_S1_M5_5351_c4591001-interim-mth6-patient-batches.pdf 1.4 MB
.pad/1403763 1.4 MB
.pad/1403355 1.4 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131255.pdf 1.4 MB
.pad/1389509 1.4 MB
.pad/1388594 1.4 MB
.pad/1384642 1.4 MB
pd-production-030122/125742_S1_M1_cover.pdf 1.4 MB
.pad/1379241 1.4 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081603.pdf 1.4 MB
.pad/1377517 1.4 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071443.pdf 1.4 MB
.pad/1365545 1.4 MB
.pad/1362804 1.4 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131165.pdf 1.4 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071159.pdf 1.4 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-excluded-patients.pdf 1.4 MB
.pad/1347939 1.3 MB
.pad/1343098 1.3 MB
.pad/1341310 1.3 MB
pd-production-040122/125742_S1_M5_5351_c4591001-interim-mth6-audit-certificates.pdf 1.3 MB
.pad/1336256 1.3 MB
.pad/1336256 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081667.pdf 1.3 MB
pd-production-060122/125742_S1_M5_5351_c4591001-fa-interim-patient-batches.pdf 1.3 MB
.pad/1325761 1.3 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-compliance-sensitive.pdf 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1009-10091123.pdf 1.3 MB
.pad/1313904 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071441.pdf 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081337.pdf 1.3 MB
.pad/1302241 1.3 MB
.pad/1299317 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151035.pdf 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151089.pdf 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131653.pdf 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151071.pdf 1.3 MB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851216.pdf 1.3 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-efficacy-response.pdf 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131656.pdf 1.3 MB
.pad/1276453 1.3 MB
.pad/1276006 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081056.pdf 1.3 MB
.pad/1270502 1.3 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-notes-for-reader.pdf 1.3 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-compliance-sensitive.pdf 1.3 MB
pd-production-060122/125742_S1_M5_5351_c4591001-interim-mth6-randomization.pdf 1.3 MB
pd-production-050222/125742_S1_M5_bnt162-01-S-csdrg.pdf 1.3 MB
pd-production-040122/125742_S1_M5_5351_c4591001-interim-mth6-adverse-events-sensitive.pdf 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1011-10111181.pdf 1.3 MB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851116.pdf 1.3 MB
.pad/1249150 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081628.pdf 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081184.pdf 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131517.pdf 1.2 MB
pd-production-040122/125742_S1_M5_5351_c4591001-interim-mth6-invest-signature.pdf 1.2 MB
.pad/1230815 1.2 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-protocol-deviations.pdf 1.2 MB
.pad/1215839 1.2 MB
.pad/1213179 1.2 MB
.pad/1207121 1.2 MB
.pad/1205797 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131229.pdf 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151047.pdf 1.2 MB
.pad/1201104 1.2 MB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851246.pdf 1.2 MB
.pad/1188889 1.2 MB
.pad/1186662 1.2 MB
.pad/1184699 1.2 MB
.pad/1171272 1.2 MB
.pad/1167910 1.2 MB
.pad/1167907 1.2 MB
.pad/1158880 1.2 MB
.pad/1147686 1.1 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-iec-irb.pdf 1.1 MB
.pad/1143388 1.1 MB
.pad/1132677 1.1 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131658.pdf 1.1 MB
.pad/1116549 1.1 MB
.pad/1114370 1.1 MB
.pad/1112688 1.1 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151101.pdf 1.1 MB
.pad/1089995 1.1 MB
.pad/1088003 1.1 MB
.pad/1086306 1.1 MB
pd-production-030122/125742_S1_M1_us-agent-authorization.pdf 1.1 MB
.pad/1064656 1.1 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081152.pdf 1.1 MB
.pad/1053605 1.1 MB
.pad/1051178 1.1 MB
.pad/1050398 1.1 MB
.pad/1048726 1.0 MB
pd-production-070122/125742_S2_M1_com195lkz-carton-kzoo.pdf 1.0 MB
pd-production-070122/125742_S2_M1_loa-dmf-011321-vials.pdf 1.0 MB
.pad/1033564 1.0 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131386.pdf 1.0 MB
.pad/1012417 1.0 MB
pd-production-070122/125742_S2_M1_hospira-diluent-carton.pdf 1.0 MB
pd-production-050222/FDA-CBER-2021-5683-0058829 to -0058954_125742_S1_M5_bnt162-01-S-define.xml 1.0 MB
pd-production-111721/5.3.6-postmarketing-experience.pdf 1.0 MB
.pad/995171 995.2 kB
.pad/987283 987.3 kB
pd-production-040122/reissue_5.3.6 postmarketing experience.pdf 980.6 kB
.pad/977908 977.9 kB
.pad/962962 963.0 kB
.pad/950478 950.5 kB
.pad/940784 940.8 kB
pd-production-050222/FDA-CBER-2021-5683-0058479 to -0058594_125742_S1_M5_c4591001-S-define.xml 925.9 kB
.pad/925235 925.2 kB
pd-production-050222/125742_S1_M5_bnt162-01-A-adrg.pdf 912.5 kB
.pad/911785 911.8 kB
pd-production-030122/125742_S1_M5_5351_c4591001-ad-hoc-label-tables.pdf 910.5 kB
.pad/898888 898.9 kB
.pad/896320 896.3 kB
.pad/893160 893.2 kB
.pad/892619 892.6 kB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-audit-certificates.pdf 890.0 kB
.pad/886416 886.4 kB
pd-production-070122/125742_S2_M1_comvlabkz-vial-kzoo.pdf 884.0 kB
.pad/881840 881.8 kB
pd-production-070122/125742_S2_M1_loa-dmf-10953-stopper.pdf 881.3 kB
.pad/871933 871.9 kB
pd-production-030122/125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.pdf 866.3 kB
.pad/860055 860.1 kB
.pad/859029 859.0 kB
.pad/857540 857.5 kB
.pad/854879 854.9 kB
.pad/854544 854.5 kB
.pad/852594 852.6 kB
pd-production-050222/FDA-CBER-2021-5683-0058676 to -0058794_125742_S1_M5_bnt162-01-A-define.xml 848.0 kB
.pad/845807 845.8 kB
.pad/845473 845.5 kB
.pad/841741 841.7 kB
.pad/841024 841.0 kB
.pad/840900 840.9 kB
.pad/837915 837.9 kB
.pad/832387 832.4 kB
.pad/824405 824.4 kB
.pad/823457 823.5 kB
.pad/819876 819.9 kB
.pad/817399 817.4 kB
.pad/814548 814.5 kB
.pad/814399 814.4 kB
.pad/812613 812.6 kB
.pad/809088 809.1 kB
.pad/804898 804.9 kB
.pad/801861 801.9 kB
.pad/799039 799.0 kB
pd-production-070122/125742_S2_M1_hospira-diluent-label.pdf 794.9 kB
.pad/793893 793.9 kB
.pad/790028 790.0 kB
.pad/778558 778.6 kB
.pad/778153 778.2 kB
.pad/771179 771.2 kB
.pad/767836 767.8 kB
.pad/759015 759.0 kB
.pad/758343 758.3 kB
pd-production-030122/125742_S1_M5_c4591001-T-S-suppl-arg.pdf 755.8 kB
.pad/745371 745.4 kB
.pad/741690 741.7 kB
.pad/735942 735.9 kB
pd-production-030122/125742_S1_M1_trans-of-oblig.pdf 734.3 kB
pd-production-030122/125742_S1_M1_356h.pdf 731.6 kB
.pad/727002 727.0 kB
.pad/721024 721.0 kB
pd-production-030122/125742_S1_M5_c4591001-T-S-roadmap.pdf 719.6 kB
.pad/718596 718.6 kB
pd-production-070122/125742_S2_M1_loa-dmf-011793-vials.pdf 717.9 kB
.pad/717662 717.7 kB
pd-production-030122/125742_S1_M1_financial-cert-bias.pdf 712.5 kB
pd-production-050222/FDA-CBER-2021-5683-0058316 to -0058458_125742_S1_M5_c4591001-A-Supp-define.xml 708.6 kB
pd-production-070122/125742_S2_M1_com195lpus-carton-puurs.pdf 707.6 kB
.pad/697841 697.8 kB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-invest-signature.pdf 693.4 kB
.pad/692090 692.1 kB
.pad/688988 689.0 kB
pd-production-070122/125742_S2_M1_com25ctpus-carton-puurs.pdf 688.0 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-any-malignancy.pdf 686.3 kB
pd-production-030122/125742_S1_M2_22_introduction.pdf 686.3 kB
.pad/683323 683.3 kB
pd-production-030122/125742_S1_M5_c4591001-T-S-summary-differences-csr-vs-update.pdf 682.8 kB
.pad/682006 682.0 kB
pd-production-030122/125742_S1_M1_ipsp-agreed-letter.pdf 673.6 kB
pd-production-030122/125742_S1_M1_debarment.pdf 672.2 kB
pd-production-030122/125742_S1_M1_fast-track-designation.pdf 665.0 kB
pd-production-070122/125742_S2_M1_comvlabp-vial-puurs.pdf 663.9 kB
.pad/659504 659.5 kB
.pad/659438 659.4 kB
.pad/659116 659.1 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-lymphoma.pdf 655.5 kB
.pad/653899 653.9 kB
pd-production-030122/125742_S1_M5_c4591001-A-comorbidity-categories.pdf 652.2 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.pdf 650.9 kB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-invest-signature.pdf 649.6 kB
pd-production-030122/125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.pdf 649.5 kB
.pad/647120 647.1 kB
pd-production-070122/125742_S2_M1_com25ctkz-carton-kzoo.pdf 647.1 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-cerebrovascular.pdf 646.8 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-periph-vasc.pdf 646.8 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-leukemia.pdf 646.6 kB
pd-production-070122/125742_S2_M1_loa-dmf-012683-vials.pdf 646.0 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-pulmonary.pdf 644.7 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-rheumatic.pdf 644.5 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-aids-hiv.pdf 644.2 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-renal.pdf 644.0 kB
.pad/643776 643.8 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-mild-liver.pdf 643.4 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-chf.pdf 643.3 kB
pd-production-030122/125742_S1_M1_userfee.pdf 642.9 kB
pd-production-030122/125742_S1_M5_c4591001-A-bmi-12-15-scale.pdf 642.1 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.pdf 641.8 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-dementia.pdf 640.8 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.pdf 640.7 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.pdf 640.7 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-hemiplegia.pdf 640.6 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.pdf 639.8 kB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-mi.pdf 639.2 kB
.pad/636912 636.9 kB
.pad/635099 635.1 kB
pd-production-030122/125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.pdf 635.1 kB
.pad/633915 633.9 kB
.pad/632736 632.7 kB
.pad/632511 632.5 kB
pd-production-070122/125742_S2_M1_loa-dmf-011820-vials.pdf 631.0 kB
pd-production-030122/125742_S1_M1_exclusivity-claim.pdf 630.9 kB
.pad/629773 629.8 kB
.pad/625173 625.2 kB
pd-production-070122/125742_S2_M1_fk-diluent-carton.pdf 621.7 kB
pd-production-030122/125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.pdf 621.5 kB
pd-production-030122/125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.pdf 616.7 kB
pd-production-070122/125742_S2_M1_fk-diluent-stamp.pdf 612.6 kB
.pad/609976 610.0 kB
.pad/603729 603.7 kB
.pad/601728 601.7 kB
.pad/600698 600.7 kB
.pad/600163 600.2 kB
.pad/594476 594.5 kB
.pad/594323 594.3 kB
.pad/593072 593.1 kB
.pad/592102 592.1 kB
.pad/590670 590.7 kB
.pad/584327 584.3 kB
.pad/582248 582.2 kB
pd-production-070122/FDA-CBER-2021-5683-0286072 to -0286266_125742_S1_M5_c4591001-S-Supp-D-relrec.xpt 581.8 kB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002376_relrec.xpt 580.2 kB
.pad/577797 577.8 kB
.pad/575971 576.0 kB
.pad/562980 563.0 kB
.pad/562720 562.7 kB
.pad/557732 557.7 kB
.pad/555658 555.7 kB
.pad/555434 555.4 kB
.pad/552114 552.1 kB
.pad/550361 550.4 kB
.pad/547979 548.0 kB
.pad/525081 525.1 kB
.pad/518792 518.8 kB
.pad/515047 515.0 kB
.pad/512521 512.5 kB
.pad/508004 508.0 kB
.pad/501069 501.1 kB
.pad/495274 495.3 kB
pd-production-070122/FDA-CBER-2021-5683-0282329 to -0282365_125742_S1_M5_c4591001-S-D-ie.xpt 491.1 kB
.pad/489504 489.5 kB
.pad/484750 484.8 kB
.pad/478144 478.1 kB
.pad/470569 470.6 kB
.pad/463782 463.8 kB
.pad/462617 462.6 kB
.pad/446062 446.1 kB
.pad/439744 439.7 kB
.pad/432507 432.5 kB
.pad/429379 429.4 kB
.pad/408351 408.4 kB
.pad/407232 407.2 kB
.pad/398152 398.2 kB
.pad/391315 391.3 kB
.pad/388238 388.2 kB
.pad/387110 387.1 kB
.pad/384753 384.8 kB
.pad/357464 357.5 kB
.pad/327366 327.4 kB
.pad/325554 325.6 kB
.pad/313184 313.2 kB
.pad/312541 312.5 kB
.pad/308694 308.7 kB
pd-production-050222/FDA-CBER-2021-5683-0058615 to -0058652_125742_S1_M5_c4591001-S-Supp-define.xml 307.0 kB
.pad/303249 303.2 kB
.pad/299998 300.0 kB
.pad/297052 297.1 kB
.pad/293877 293.9 kB
.pad/293428 293.4 kB
.pad/282076 282.1 kB
.pad/274455 274.5 kB
.pad/273415 273.4 kB
.pad/264301 264.3 kB
.pad/263583 263.6 kB
.pad/249009 249.0 kB
.pad/248172 248.2 kB
.pad/245954 246.0 kB
.pad/245429 245.4 kB
.pad/234376 234.4 kB
pd-production-121321/signed-F21-5683-CBER-Dec-13-2021-Response-Letter.pdf 211.5 kB
.pad/204688 204.7 kB
pd-production-030122/FDA-CBER-2021-5683-0022867 to -0023006_125742_S1_M5_c4591001-A-P-adsl-sas.txt 201.9 kB
.pad/201198 201.2 kB
pd-production-030122/FDA-CBER-2021-5683-0022136 to -0022325_125742_S1_M5_c4591001-A-P-adce-s020-se-p3-saf-sas.txt 197.5 kB
.pad/196859 196.9 kB
.pad/193244 193.2 kB
pd-production-030122/FDA-CBER-2021-5683-0023455 to -0023486_125742_S1_M5_c4591001-A-define-2-0-0.xsl 187.7 kB
pd-production-050222/FDA-CBER-2021-5683-0058459 to -0058478_125742_S1_M5_c4591001-A-Supp-define-2-0-0.xsl 187.7 kB
pd-production-050222/FDA-CBER-2021-5683-0058595 to -0058614_125742_S1_M5_c4591001-S-define-2-0-0.xsl 187.7 kB
pd-production-050222/FDA-CBER-2021-5683-0058653 to -0058675_125742_S1_M5_c4591001-S-Supp-define-2-0-0.xsl 187.7 kB
pd-production-050222/FDA-CBER-2021-5683-0058795 to -0058828_125742_S1_M5_bnt162-01-A-define-2-0-0.xsl 187.7 kB
pd-production-050222/FDA-CBER-2021-5683-0058955 to -0058999_125742_S1_M5_bnt162-01-S-define-2-0-0.xsl 187.7 kB
.pad/163943 163.9 kB
pd-production-030122/FDA-CBER-2021-5683-0022365 to -0022560_125742_S1_M5_c4591001-A-P-adds-s002-all-p3-rand-sas.txt 159.5 kB
.pad/128947 128.9 kB
.pad/124421 124.4 kB
.pad/105781 105.8 kB
.pad/96323 96.3 kB
pd-production-030122/FDA-CBER-2021-5683-0023711 to -0023875_125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.xlsx 86.2 kB
pd-production-030122/FDA-CBER-2021-5683-0021981 to -0022027_125742_S1_M5_c4591001-A-P-adc19ef-sas.txt 83.0 kB
pd-production-070122/FDA-CBER-2021-5683-0285644 to -0285651_125742_S1_M5_c4591001-S-D-mo.xpt 77.6 kB
pd-production-030122/FDA-CBER-2021-5683-0022793 to -0022866_125742_S1_M5_c4591001-A-P-adsl-s005-demo-all-p3-saf-sas.txt 77.2 kB
pd-production-030122/FDA-CBER-2021-5683-0022692 to -0022765_125742_S1_M5_c4591001-A-P-adsl-demo-7d-wwo-eval-eff-sas.txt 76.5 kB
pd-production-030122/FDA-CBER-2021-5683-0022618 to -0022691_125742_S1_M5_c4591001-A-P-adsl-demo-7d-eval-eff-sas.txt 76.4 kB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002377_supppr.xpt 73.5 kB
pd-production-030122/FDA-CBER-2021-5683-0022063 to -0022135_125742_S1_M5_c4591001-A-P-adce-s010-lr-p3-saf-sas.txt 73.3 kB
.pad/66254 66.3 kB
.pad/62752 62.8 kB
.pad/56828 56.8 kB
pd-production-030122/FDA-CBER-2021-5683-0022568 to -0022600_125742_S1_M5_c4591001-A-P-adfacevd-sas.txt 50.1 kB
.pad/48583 48.6 kB
pd-production-030122/FDA-CBER-2021-5683-0023032 to -0023065_125742_S1_M5_c4591001-A-P-adva-sas.txt 45.9 kB
pd-production-030122/FDA-CBER-2021-5683-0023007 to -0023031_125742_S1_M5_c4591001-A-P-adsympt-sas.txt 44.3 kB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002380_ti.xpt 37.8 kB
pd-production-030122/FDA-CBER-2021-5683-0021944 to -0021963_125742_S1_M5_c4591001-A-P-adae-sas.txt 36.3 kB
pd-production-030122/FDA-CBER-2021-5683-0023895 to -0023915_125742_S1_M5_c4591001-A-report-cci-any-malignancy.xlsx 35.6 kB
pd-production-030122/FDA-CBER-2021-5683-0022346 to -0022364_125742_S1_M5_c4591001-A-P-adcm-sas.txt 33.0 kB
pd-production-030122/FDA-CBER-2021-5683-0022766 to -0022792_125742_S1_M5_c4591001-A-P-adsl-fu-d2-p3-saf-sas.txt 29.9 kB
pd-production-030122/FDA-CBER-2021-5683-0023500 to -0023507_125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.xlsx 29.4 kB
pd-production-030122/FDA-CBER-2021-5683-0022326 to -0022345_125742_S1_M5_c4591001-A-P-adcevd-sas.txt 27.8 kB
.pad/27462 27.5 kB
pd-production-030122/FDA-CBER-2021-5683-0022601 to -0022617_125742_S1_M5_c4591001-A-P-admh-sas.txt 24.6 kB
pd-production-030122/FDA-CBER-2021-5683-0023983 to -0023984_125742_S1_M5_c4591001-A-report-cci-rheumatic.xlsx 24.5 kB
pd-production-030122/FDA-CBER-2021-5683-0023878_125742_S1_M5_c4591001-A-report-cci-aids-hiv.xlsx 23.3 kB
pd-production-030122/FDA-CBER-2021-5683-0023550 to -0023569_125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.xlsx 22.8 kB
pd-production-030122/FDA-CBER-2021-5683-0023987_125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.xlsx 21.8 kB
pd-production-030122/FDA-CBER-2021-5683-0022028 to -0022040_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-sg-eval-sas.txt 20.0 kB
pd-production-030122/FDA-CBER-2021-5683-0022041 to -0022053_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-wo-sg-eval-sas.txt 19.9 kB
pd-production-030122/FDA-CBER-2021-5683-0023540_125742_S1_M5_c4591001-A-comorbidity-categories.xlsx 19.3 kB
pd-production-030122/FDA-CBER-2021-5683-0023523 to -0023538_125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.xlsx 18.9 kB
pd-production-030122/FDA-CBER-2021-5683-0021964 to -0021980_125742_S1_M5_c4591001-A-P-adae-vax-tier2-p3-saf-sas.txt 18.4 kB
pd-production-030122/FDA-CBER-2021-5683-0023944 to -0023950_125742_S1_M5_c4591001-A-report-cci-lymphoma.xlsx 17.4 kB
.pad/16016 16.0 kB
pd-production-111721/BATES-93_tv.xpt 15.9 kB
pd-production-030122/FDA-CBER-2021-5683-0021930 to -0021943_125742_S1_M5_c4591001-A-P-adae-s092-cr-cut-p3x-saf-sas.txt 15.5 kB
.pad/15248 15.2 kB
pd-production-030122/FDA-CBER-2021-5683-0021916 to -0021929_125742_S1_M5_c4591001-A-P-adae-s092-all-unb-p3-saf-sas.txt 15.1 kB
pd-production-030122/FDA-CBER-2021-5683-0021902 to -0021915_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf2-sas.txt 15.0 kB
pd-production-030122/FDA-CBER-2021-5683-0023955 to -0023958_125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.xlsx 14.7 kB
pd-production-030122/FDA-CBER-2021-5683-0021888 to -0021901_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf1-sas.txt 14.2 kB
pd-production-030122/FDA-CBER-2021-5683-0023490 to -0023491_125742_S1_M5_c4591001-A-bmi-12-15-scale.xlsx 13.3 kB
pd-production-030122/FDA-CBER-2021-5683-0023919 to -0023921_125742_S1_M5_c4591001-A-report-cci-cerebrovascular.xlsx 12.7 kB
pd-production-030122/FDA-CBER-2021-5683-0022054 to -0022062_125742_S1_M5_c4591001-A-P-adc19ef-ve-sev-cov-pd1-aai-sas.txt 12.6 kB
pd-production-030122/FDA-CBER-2021-5683-0023971 to -0023972_125742_S1_M5_c4591001-A-report-cci-periph-vasc.xlsx 12.0 kB
pd-production-030122/FDA-CBER-2021-5683-0023936 to -0023937_125742_S1_M5_c4591001-A-report-cci-leukemia.xlsx 12.0 kB
pd-production-030122/FDA-CBER-2021-5683-0023975 to -0023976_125742_S1_M5_c4591001-A-report-cci-pulmonary.xlsx 11.8 kB
.pad/11541 11.5 kB
pd-production-030122/FDA-CBER-2021-5683-0023979 to -0023980_125742_S1_M5_c4591001-A-report-cci-renal.xlsx 11.4 kB
pd-production-030122/FDA-CBER-2021-5683-0022561 to -0022567_125742_S1_M5_c4591001-A-P-adds-sas.txt 11.3 kB
pd-production-030122/FDA-CBER-2021-5683-0023963_125742_S1_M5_c4591001-A-report-cci-mild-liver.xlsx 10.6 kB
pd-production-030122/FDA-CBER-2021-5683-0023924_125742_S1_M5_c4591001-A-report-cci-chf.xlsx 10.5 kB
pd-production-030122/FDA-CBER-2021-5683-0023930_125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.xlsx 10.0 kB
pd-production-030122/FDA-CBER-2021-5683-0023932_125742_S1_M5_c4591001-A-report-cci-hemiplegia.xlsx 9.8 kB
pd-production-030122/FDA-CBER-2021-5683-0023926_125742_S1_M5_c4591001-A-report-cci-dementia.xlsx 9.7 kB
pd-production-030122/FDA-CBER-2021-5683-0023928_125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.xlsx 9.4 kB
pd-production-030122/FDA-CBER-2021-5683-0023965_125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.xlsx 9.4 kB
pd-production-030122/FDA-CBER-2021-5683-0023967_125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.xlsx 9.4 kB
pd-production-111721/BATES-92_adc19ef-ve-cov-7pd2-wo-eval-sas.txt 9.3 kB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002374_adc19ef-ve-sev-cov-7pd2-wo-eval-sas.txt 9.3 kB
pd-production-030122/FDA-CBER-2021-5683-0023960_125742_S1_M5_c4591001-A-report-cci-mi.xlsx 9.1 kB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002373_adc19ef-ve-sev-cov-7pd2-eval-sas.txt 8.7 kB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002372_adc19ef-ve-cov-7pd2-eval-sas.txt 8.7 kB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002378_ta.xpt 8.6 kB
.pad/6144 6.1 kB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002375_addv-sas.txt 4.6 kB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002379_te.xpt 3.4 kB

==查看完整文档列表==

上一个：Wondershare Filmora 2024 v13.0.60.5095 (x64) + Patch [New 2024]494.2 MB
下一个：[susun]小妖精自慰纯白色 297.7 MB

24小时热门磁力链接

Andor [HDTV 720p][Cap.205] 8145次下载 Cap HDTV 720p
Маня и Груня.2024.WEB-DL 720p.Files-x 5109次下载 2024 WEB DL
Havoc.2025.1080p.NF.WEB-DL.DDP5.1.Atmos.H.264-EniaHD.mkv 5077次下载 WEB DL DDP5
The.Super.Cube.S01E09.1080p.iQ.WEB-DL.AAC2.0.H.264-VARYG.mkv 5040次下载 WEB DL Cube
Star.Wars.Andor.S02E05.I.Have.Friends.Everywhere.1080p.DS... 4944次下载 WEB DL Star
新桥恋人.电影港地址发布页 www.dygang.me 收藏不迷路 4365次下载 me www 发布页
Night at the Museum Battle of the Smithsonian 2009 2160p... 4161次下载 KiNGDOM WEB DL
www.UIndex.org - ... 4126次下载 www MeGusta HEVC
Palma.2.2024.WEB-DL.1080p.ExKinoRay.mkv 4000次下载 WEB DL 2.2024
Guns N' Roses - Greatest Hits Live Broadcast Collection... 3915次下载 Live Remastered Hits

本周热门磁力链接

Andor [HDTV 720p][Cap.205] 8145次下载 Cap HDTV 720p
(同人CG集) [白色絵の具 (無味ムスミ)] 友達の母が巨乳で金髪の淫乱美女でした.zip 6346次下载 zip 巨乳 CG
You.S05E02.720p.HEVC.x265-MeGusta[EZTVx.to].mkv 6221次下载 S05E02 HEVC 720p
up-mod-minecraft-play-with-friends-v1-21-80-28-... 6023次下载 982108028 mod play
the.last.of.us.s02e02.1080p.web.h264-successful... 5335次下载 web last h264
异世降临.6v电影地址发布页 www.6v123.net 收藏不迷路 5220次下载 www 发布页 6v123
Opasnaya.blizost.S01.2025.WEB-DL.1080p 5127次下载 WEB DL S01
Маня и Груня.2024.WEB-DL 720p.Files-x 5109次下载 2024 WEB DL
Andor.S02E02.Sagrona.Teema.1080p.HEVC.x265-MeGu... 5100次下载 HEVC Andor mkv
Havoc.2025.1080p.NF.WEB-DL.DDP5.1.Atmos.H.264-E... 5077次下载 WEB DL DDP5

种子标签

种子评价

优质的种子 (0) 假种子 (0) 有密码 (0) 低质量 (0) 有病毒 (0) 无法下载 (0)
欢迎对种子质量进行评价。

人气女优

北川ゆい Akira COCOLO Saiko あいだももあさのくるみあまいれもんいしかわ愛里いとうしいなうさみ恭香うちだまひろかぐやひめかとりこのみかないかほくすのき琴美クミコグレースくらもとまい（葉月ありさ）さとみ中村あみしいな純菜しのざきさとみ（三沢亜也）牧本千幸（つかもと友希）眞木ありさデヴィテラパトリックドミニカともさかまいともさか愛なごみもえひなこ

分享BT种子/磁力链接

亲，你知道吗？下载的人越多速度越快，赶快把本页面分享给好友一起下载吧^_^

磁力管家